Global Biopreservation Market

Biopreservation Market Size, Share, Growth Analysis, By Product(Equipment, Media, and Laboratory Information Management System (LIMS)), By Application(Regenerative Medicine, Bio-banking, and Drug Discovery), By Region - Industry Forecast 2025-2032


Report ID: SQMIG35I2223 | Region: Global | Published Date: March, 2024
Pages: 219 | Tables: 63 | Figures: 75

Biopreservation Market Insights

Biopreservation Market size was valued at USD 2.8 Billion in 2023 and is poised to grow from USD 3.59 Billion in 2024 to USD 26.35 Billion by 2032, growing at a CAGR of 28.30% during the forecast period (2025-2032).

Biopreservation is a method which ensures the preservation of the property and functionality of biomass and biological products in a wide range of temperature and other physical conditions. Biomass and biological products can range from DNA, tissues, and organs to stem cells. Recent technological advancement enables the use of microarrays and the integration of diverse predictive models for biopreservation. Implementation of technology and API algorithms in biopreservation have collectively minimized the time, cost, and complexity associated with the entire process. Additionally, the emergence of multiplex cellular imaging platforms is expected to significantly improve biopreservation capabilities further. Biopreservation finds wider acceptance in cardiology, gynecology, and point-of-care applications. 

Growing prevalence of chronic diseases worldwide is boosting the development of biological products across various research and development sectors, including immunotherapies, vaccine production, antibody generation, enzyme technology, and biologically derived chemicals. In recent years, this trend has largely been attributed to the increase in the demand for biopreservation techniques. The Biopreservation Market is witnessing significant collaboration between government and private sectors by providing financial support for research and development initiatives. Increasing demand for stem cell preservation, creation of biological medicines and products is attracting attention of biomedicine companies for biopreservation. The notable growth in healthcare expenditure is anticipated to drive market expansion throughout the forecast period.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Biopreservation Market size was valued at USD 2.18 billion in 2022 and is poised to grow from USD 2.80 billion in 2023 to USD 20.54 billion by 2031, growing at a CAGR of 28.30% during the forecast period (2024-2031).

Biopreservation market is capital and innovation extensive hence it is dominated by large multinational companies. There is a higher degree of collaboration between the government and private sector in terms of research and funding. Government regulations are also on the higher side in the market, and they vary for each geography. Hence, companies with wider regional outreach have a competitive edge.  'Thermo Fisher Scientific Inc.', 'Merck KGaA', 'BioLife Solutions, Inc.', 'GE Healthcare', 'VWR International LLC', 'Custom Biogenic Systems, Inc.', 'Chart Industries, Inc.', 'BioCision LLC', 'STEMCELL Technologies Inc.', 'Cesca Therapeutics Inc.', 'Core Dynamics Ltd.', 'Panasonic Healthcare Co., Ltd.', 'Avantor, Inc.', 'Lonza Group Ltd.', 'Brooks Automation, Inc.', 'BioStorage Technologies, Inc.', 'LabVantage Solutions, Inc.', 'Atlanta Biologicals, Inc.', 'Hamilton Company', 'So-Low Environmental Equipment Co.'

Reported chronic diseases cases are on the rise globally. In developed economies such as the US chronic disease was reported annually in more than 30% of the adult population while in developing economies such as India, chronic diseases were reported in more than 23% of the adult population. Chronic diseases have high requirement of diagnosis and other alternate therapies thus boosting the demand for biopreservation. 

Cell therapy and genetic engineering demand is expected to witness more than 30% CAGR during the forecast period. This is attracting investment from biomedical companies for research and development. Cell and gene therapy is transforming the diagnosis and treatment of critical patients and chronic diseases. Government spending on research centers focusing on gene therapy and regenerative treatment is also expected to grow. 

North America dominated the market and accounted for highest Biopreservation Market share in 2023, driven by flourishing healthcare sector and growing budget for pharmaceutical research. US accounts for the largest market for clinical trials of new drugs and is the powerhouse of drug discovery. The presence of research centers of large pharmaceutical companies and world class healthcare providers creates high demand for biopreservation of samples required in treatment and research. In addition, the number of cases of chronic disease is significantly high and acceptance of personalized medication using regenerative techniques is also significantly more mature in North America especially in the US. 

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Biopreservation Market

Report ID: SQMIG35I2223

$5,300
BUY NOW GET FREE SAMPLE